Dian Faradiba

ORCID: 0000-0001-7967-3109
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 epidemiological studies
  • Health Systems, Economic Evaluations, Quality of Life
  • Vaccine Coverage and Hesitancy
  • Pharmaceutical Economics and Policy
  • COVID-19 Digital Contact Tracing
  • Healthcare Systems and Reforms
  • SARS-CoV-2 and COVID-19 Research
  • Antibiotic Use and Resistance
  • Pharmaceutical Practices and Patient Outcomes
  • Global Maternal and Child Health
  • Immune responses and vaccinations
  • Healthcare Policy and Management
  • COVID-19 Clinical Research Studies
  • COVID-19 Pandemic Impacts

Health Intervention and Technology Assessment Program
2022-2023

Ministry of Public Health
2022-2023

There has been an increasing demand to reimburse high-cost medicines, through public health insurance schemes in Thailand. A mixed method approach was employed. First, a rapid review of select high-income countries conducted, followed by expert consultations and in-depth three countries: Australia, England Republic Korea understand reimbursement mechanisms medicines. In Thailand, current pathways for reimbursing medicines reviewed, the potential opportunity cost estimated, stakeholder were...

10.1186/s40545-023-00643-z article EN cc-by Journal of Pharmaceutical Policy and Practice 2023-11-07

There are ongoing calls to harmonise and increase the use of COVID-19 vaccination certificates (CVCs) in Asia. Identifying groups Asian societies who oppose CVCs understanding their reasons can help formulate an effective policy region. However, no formal studies have explored this issue Asia.The Vaccination Policy Research Decision-Support Initiative Asia (CORESIA) was established address questions related CVCs. An online cross-sectional survey conducted from June October 2021 nine...

10.1016/j.tmaid.2022.102358 article EN cc-by-nc-nd Travel Medicine and Infectious Disease 2022-05-17

With countries progressing towards high COVID-19 vaccination rates, strategies for border reopening are required. This study focuses on Thailand and Singapore, two that share significant tourism visitation, to illustrate a framework optimizing testing quarantine policies bilateral travel with focus economic recovery. The timeframe is the month of October 2021, when Singapore were preparing reopen borders travel. was conducted provide evidence policy decisions. Incremental net benefit (INB)...

10.3390/ijerph20054011 article EN International Journal of Environmental Research and Public Health 2023-02-23

Objectives: This study aims to assess the trade-offs between vulnerability and efficiency attributes of contact tracing programmes based on preferences COVID-19 practitioners, researchers other relevant stakeholders at global level. Methods: We conducted an online discrete choice experiment (DCE). Respondents were recruited globally explore according country income level prevailing epidemiology in local setting. The DCE represented (timeliness, completeness, number contacts), (vulnerable...

10.3389/ijph.2022.1604958 article EN cc-by International Journal of Public Health 2022-07-20

COVID-19 vaccination certificates (CVCs) have played a key role in safe reopening of borders for international travel and trade, so understanding stakeholder perceptions enablers barriers their effective use is critical. The Vaccination Policy Research Deci-sion-Support Initiative Asia (CORESIA) was established to address policy questions related CVCs. We conducted two online surveys, i.e., one the public health non-health sector experts, from June October 2021 nine Asian countries....

10.20944/preprints202208.0423.v1 preprint EN 2022-08-24

Background: Contact tracing is an important tool to control the spread of infectious diseases, including COVID-19. This study aims assess trade-offs between efficiency and equity attributes contact programmes based on preferences COVID-19 practitioners, researchers other relevant stakeholders.Methods: We conducted online discrete choice experiment (DCE). The DCE represented (timeliness, completeness, number contacts), (vulnerability), cooperation, privacy. Respondents were recruited globally...

10.2139/ssrn.4038202 article EN SSRN Electronic Journal 2022-01-01

Background: The government regulates the application of new technologies in national insurance benefit packages should correspond to health technology assessment (HTA).Objective. Understanding current methodology, reporting, and source evidence quality studies for Indonesia could inform future improvement usability reimbursement decision-making.Methods: A systematic review method was used search relevant using inclusion exclusion criteria. methodology reporting included were appraised...

10.2139/ssrn.4147505 article EN SSRN Electronic Journal 2022-01-01
Coming Soon ...